Dimensional Fund Advisors LP Xenon Pharmaceuticals Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 299,865 shares of XENE stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

299,865

Previous 436,460 31.3%

Holding current value

$11.7 Million

Previous $17 Million 30.66%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$36.12 - $43.96 $4.93 Million - $6 Million	-136,595 Reduced 31.3%	299,865 $11.8 Million
Q2 2024 Aug 09, 2024	BUY	$36.25 - $43.75 $951,671 - $1.15 Million	26,253 Added 6.4%	436,460 $17 Million
Q1 2024 May 10, 2024	BUY	$42.66 - $50.04 $321,613 - $377,251	7,539 Added 1.87%	410,207 $17.7 Million
Q4 2023 Feb 07, 2024	SELL	$28.7 - $46.46 $701,915 - $1.14 Million	-24,457 Reduced 5.73%	402,668 $18.5 Million
Q3 2023 Nov 09, 2023	BUY	$34.16 - $39.73 $5.64 Million - $6.56 Million	165,018 Added 62.96%	427,125 $14.6 Million
Q2 2023 Aug 09, 2023	BUY	$34.84 - $43.54 $6.86 Million - $8.57 Million	196,841 Added 301.6%	262,107 $10.1 Million
Q1 2023 May 12, 2023	SELL	$33.46 - $40.35 $8.35 Million - $10.1 Million	-249,407 Reduced 79.26%	65,266 $2.34 Million
Q4 2022 Feb 09, 2023	SELL	$33.06 - $39.43 $904,455 - $1.08 Million	-27,358 Reduced 8.0%	314,673 $12.4 Million
Q3 2022 Nov 10, 2022	BUY	$30.79 - $39.82 $5.14 Million - $6.65 Million	167,069 Added 95.49%	342,031 $12.3 Million
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $3.02 Million - $4.18 Million	-118,767 Reduced 40.43%	174,962 $5.32 Million
Q1 2022 May 13, 2022	BUY	$25.09 - $33.13 $44,735 - $59,070	1,783 Added 0.61%	293,729 $8.98 Million
Q4 2021 Feb 09, 2022	BUY	$15.6 - $35.4 $2.2 Million - $4.98 Million	140,749 Added 93.09%	291,946 $9.12 Million
Q3 2021 Nov 12, 2021	BUY	$14.86 - $19.45 $2.02 Million - $2.65 Million	136,187 Added 907.31%	151,197 $2.31 Million
Q2 2021 Aug 12, 2021	BUY	$16.81 - $20.0 $252,318 - $300,200	15,010 New	15,010 $279,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Xenon Pharmaceuticals Inc. Transaction History